Giorgio Rachel T, Helaine Sophie
Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Nat Rev Microbiol. 2025 May;23(5):276-287. doi: 10.1038/s41579-024-01124-z. Epub 2024 Nov 18.
Antibiotic-recalcitrant infections, defined as the prolonged carriage of pathogenic bacteria even in the presence of antibiotics, are often caused by bacteria that are genetically susceptible to the drug. These recalcitrant bacteria fail to proliferate in the presence of antibiotics but remain viable such that they may recolonize their niche following antibiotic withdrawal. Significant progress has been made in our understanding of antibiotic-recalcitrant Salmonella, which are thought to be the source of infection relapse. In recent years, it has been shown that recalcitrant bacteria manipulate host immune defences and could directly contribute to the spread of antimicrobial resistance. In this Review, we provide an overview of what is currently known about the antibiotic recalcitrance of Salmonella during infection and highlight knowledge gaps requiring additional research in the future.
抗生素难治性感染被定义为即使在使用抗生素的情况下病原菌仍长期存在,通常由对该药物基因敏感的细菌引起。这些难治性细菌在抗生素存在的情况下无法增殖,但仍保持存活,以便在抗生素停用后重新定殖于其生态位。我们对被认为是感染复发源头的抗生素难治性沙门氏菌已有深入了解。近年来,研究表明难治性细菌会操纵宿主免疫防御,并且可能直接导致抗菌药物耐药性的传播。在本综述中,我们概述了目前已知的沙门氏菌在感染期间的抗生素难治性情况,并强调了未来需要进一步研究的知识空白。